Wednesday, November 30, 2016 8:55:06 AM
PURE Bioscience Sets Fiscal 2017 Q1 Results Conference Call
Food Safety Solutions Update on PURE® Hard Surface and PURE Control® Antimicrobials
November 30, 2016 08:36 AM Eastern Standard Time
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that on December 14, 2016 the Company will file its Form 10-Q shortly after the close of the market. It will host an investor conference call that day at 1:30pm PST (4:30pm EST) to review 2017 Q1 financial results.
PURE management will also discuss the progress made to commercialize its two antimicrobial SDC-based food safety solutions:
PURE® Hard Surface disinfectant - The status of ongoing commercialization in restaurant chains (including Chipotle Mexican Grill) and processors/manufacturers.
PURE Control® - The status of ongoing sales and marketing of FDA approved processing aid for fresh produce; the status of the work for USDA approval for use as a raw poultry processing aid;
The Participant Dial-In Number for the conference call is 1-631-891-4304. Participants should dial in to the call at least five minutes before 1:30pm PST (4:30pm EST) on December 14, 2016. The call can also be accessed “live” online at http://public.viavid.com/index.php?id=122082.
A replay of the recorded call will be available for 90 days on the Company’s website (http://www.purebio.com/investors/events-presentations/). You can also listen to a replay of the call by dialing 1-844-512-2921 (international participants dial 1-412-317-6671) starting December 14, 2016, at 7:30pm EST through December 21, 2016 at 11:59 pm EST. Please use PIN Number 10002105.
Recent PURE News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:45:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 10:06:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 10:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 10:04:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 10:02:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 10:00:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 09:58:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 09:56:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 09:54:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/15/2024 08:05:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:05:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/14/2024 08:10:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:05:16 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 10:16:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 09:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:30:15 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/10/2024 09:30:10 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/19/2023 09:45:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/14/2023 09:10:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 09:05:40 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/30/2023 08:10:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:05:19 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM